{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:57:32Z","timestamp":1786993052928,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T00:00:00Z","timestamp":1506470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","oarsijournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.joca.2017.09.007","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T22:45:34Z","timestamp":1506638734000},"page":"1952-1961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Safety, tolerability, and pharmacodynamics of an anti-interleukin-1\u03b1\/\u03b2 dual variable domain immunoglobulin in patients with osteoarthritis of the knee: a randomized phase 1 study"],"prefix":"10.1016","volume":"25","author":[{"given":"S.X.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.B.","family":"Abramson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Attur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"Lozada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"Kosloski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Saltarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.A.","family":"Hendrickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.K.","family":"Medema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2017.09.007_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","article-title":"Role of proinflammatory cytokines in the pathophysiology of osteoarthritis","volume":"7","author":"Kapoor","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.joca.2017.09.007_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0034-7094(11)70029-0","article-title":"Cytokines and pain","volume":"61","author":"de Oliveira","year":"2011","journal-title":"Rev Bras Anestesiol"},{"key":"10.1016\/j.joca.2017.09.007_bib3","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1093\/rheumatology\/keg326","article-title":"The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis","volume":"42","author":"Dayer","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.joca.2017.09.007_bib4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.immuni.2013.08.037","article-title":"Mechanisms of NOD-like receptor-associated inflammasome activation","volume":"39","author":"Wen","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.joca.2017.09.007_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cytogfr.2011.10.001","article-title":"Understanding the mechanism of IL-1beta secretion","volume":"22","author":"Lopez-Castejon","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.joca.2017.09.007_bib6","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095","article-title":"Biologic basis for interleukin-1 in disease","volume":"87","author":"Dinarello","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.joca.2017.09.007_bib7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4161\/mabs.1.4.8755","article-title":"Molecular construction and optimization of anti-human IL-1\u03b1\/\u03b2 dual variable domain immunoglobulin (DVD-Ig) molecules","volume":"1","author":"Wu","year":"2009","journal-title":"MAbs"},{"key":"10.1016\/j.joca.2017.09.007_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2249.2007.03441.x","article-title":"The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders","volume":"149","author":"Barksby","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.joca.2017.09.007_bib9","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1172\/JCI36389","article-title":"Evidence that cytokines play a role in rheumatoid arthritis","volume":"118","author":"Brennan","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.joca.2017.09.007_bib10","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/ard.52.12.870","article-title":"Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis","volume":"52","author":"Farahat","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2017.09.007_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/rheumatology\/keh344","article-title":"Osteoarthritis, angiogenesis and inflammation","volume":"44","author":"Bonnet","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.joca.2017.09.007_bib12","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1002\/art.30360","article-title":"Increased interleukin-1beta gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis","volume":"63","author":"Attur","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2017.09.007_bib13","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1136\/annrheumdis-2013-203405","article-title":"Genes expressed in blood link osteoarthritis with apoptotic pathways","volume":"73","author":"Ramos","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2017.09.007_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.188134","article-title":"Collagenase production by rheumatoid synovial cells: stimulation by a human lymphocyte factor","volume":"195","author":"Dayer","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.joca.2017.09.007_bib15","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/0006-2952(84)90213-2","article-title":"Effects of prostaglandin E2, indomethacin, trifluoperazine and drugs affecting the cytoskeleton on collagenase production by cultured adherent rheumatoid synovial cells","volume":"33","author":"Dayer","year":"1984","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.joca.2017.09.007_bib16","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/art.1780270608","article-title":"In\u00a0vitro activation of human chondrocytes and synoviocytes by a human interleukin-1-like factor","volume":"27","author":"McGuire-Goldring","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2017.09.007_bib17","doi-asserted-by":"crossref","first-page":"16724","DOI":"10.1016\/S0021-9258(18)49315-5","article-title":"Modulation by recombinant interleukin 1 of synthesis of types I and III collagens and associated procollagen mRNA levels in cultured human cells","volume":"262","author":"Goldring","year":"1987","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.joca.2017.09.007_bib18","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1172\/JCI113823","article-title":"Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes","volume":"82","author":"Goldring","year":"1988","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.joca.2017.09.007_bib19","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/art.1780340513","article-title":"In\u00a0vivo effects of interleukin-1 on articular cartilage. Prolongation of proteoglycan metabolic disturbances in old mice","volume":"34","author":"van Beuningen","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2017.09.007_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/19420862.2015.988944","article-title":"Antibodies to watch in 2015","volume":"7","author":"Reichert","year":"2015","journal-title":"MAbs"},{"key":"10.1016\/j.joca.2017.09.007_bib21","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1186\/ar3430","article-title":"A\u00a0randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee","volume":"13","author":"Cohen","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2017.09.007_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbpa.2015.12.003","article-title":"Preclinical characterization and clinical development of ILARIS (canakinumab) for the treatment of autoinflammatory diseases","volume":"32","author":"Gram","year":"2015","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.joca.2017.09.007_bib23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/art.24096","article-title":"Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study","volume":"61","author":"Chevalier","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2017.09.007_bib24","series-title":"Full Prescribing Information","author":"ARCALYST (rilonacept)","year":"2014"},{"key":"10.1016\/j.joca.2017.09.007_bib25","series-title":"XOMA Provides Update on Gevokizumab Proof-of-Concept Program","year":"2014"},{"key":"10.1016\/j.joca.2017.09.007_bib26","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/19420862.2015.1026501","article-title":"Generation and characterization of ABT-981, a dual variable domain immunoglobulin (DVD-Ig\u2122) molecule that specifically and potently neutralizes both IL-1\u03b1 and IL-1\u03b2","volume":"7","author":"Lacy","year":"2015","journal-title":"MAbs"},{"key":"10.1016\/j.joca.2017.09.007_bib27","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/jcph.764","article-title":"Pharmacokinetics and tolerability of a dual variable domain immunoglobulin ABT-981 against IL-1\u03b1 and IL-1\u03b2 in healthy subjects and patients with osteoarthritis of the knee","volume":"56","author":"Kosloski","year":"2016","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.joca.2017.09.007_bib28","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/S1063-4584(11)60153-2","article-title":"Simultaneous targeting of IL-1A and IL-1B by a dual-variable-domain immunoglobulin (DVD-IG\u2122) prevents cartilage degradation in preclinical models of osteoarthritis","volume":"19","author":"Kamath","year":"2011","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2017.09.007_bib29","first-page":"S62","article-title":"Development and validation of mechanical allodynia as a pain readout in a preclinical model of osteoarthritis","volume":"20","author":"Kamath","year":"2012","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2017.09.007_bib30","first-page":"1833","article-title":"Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee","volume":"15","author":"Bellamy","year":"1988","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.joca.2017.09.007_bib31","first-page":"167","article-title":"The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation","volume":"30","author":"Bruce","year":"2003","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.joca.2017.09.007_bib32","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2165\/11599820-000000000-00000","article-title":"Pharmacokinetic and pharmacodynamic properties of canakinumab, a human anti-interleukin-1beta monoclonal antibody","volume":"51","author":"Chakraborty","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.joca.2017.09.007_bib33","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/ard.2003.016014","article-title":"A\u00a0multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate","volume":"63","author":"Cohen","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2017.09.007_bib34","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","article-title":"Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis","volume":"367","author":"Ruperto","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.joca.2017.09.007_bib35","series-title":"Prescribing Information","author":"KINERET\u00ae (anakinra)","year":"2015"},{"key":"10.1016\/j.joca.2017.09.007_bib36","series-title":"Summary of Product Characteristics","author":"KINERET\u00ae (anakinra)","year":"2016"},{"key":"10.1016\/j.joca.2017.09.007_bib37","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/jnnp.2004.054882","article-title":"A\u00a0randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients","volume":"76","author":"Emsley","year":"2005","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.joca.2017.09.007_bib38","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1128\/IAI.72.7.3823-3828.2004","article-title":"In\u00a0vivo interleukin-6 protects neutrophils from apoptosis in osteomyelitis","volume":"72","author":"Asensi","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.joca.2017.09.007_bib39","doi-asserted-by":"crossref","first-page":"11398","DOI":"10.1073\/pnas.0404328101","article-title":"Critical role for granulocyte colony-stimulating factor in inflammatory arthritis","volume":"101","author":"Lawlor","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.joca.2017.09.007_bib40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nri3660","article-title":"Emergency granulopoiesis","volume":"14","author":"Manz","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.joca.2017.09.007_bib41","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.21596","article-title":"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee","volume":"64","author":"Hochberg","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.joca.2017.09.007_bib42","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/11599350-000000000-00000","article-title":"Role of interleukin-1 inhibitors in osteoarthritis: an evidence-based review","volume":"29","author":"Jotanovic","year":"2012","journal-title":"Drugs Aging"},{"key":"10.1016\/j.joca.2017.09.007_bib43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/annrheumdis-2017-eular.4947","article-title":"OP0168 A phase 2a, placebo-controlled, randomized study of ABT-981, an anti-interleukin-1ALPHA and -1BETA dual variable domain immunoglobulin, to treat erosive hand osteoarthritis (EHOA)","volume":"76","author":"Kloppenburg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2017.09.007_bib44","first-page":"1196","article-title":"Safety and efficacy of ABT-981, an anti-interleukin-1\u03b1\/\u03b2 dual variable domain (DVD) immunoglobulin, in subjects with knee osteoarthritis: results from the randomized, double-blind, placebo-controlled, parallel-group phase 2 trial","volume":"69","author":"Fleischmann","year":"2017","journal-title":"Arthritis Rheum"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458417312128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458417312128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T18:57:05Z","timestamp":1750877825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458417312128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1063458417312128"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2017.09.007","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety, tolerability, and pharmacodynamics of an anti-interleukin-1\u03b1\/\u03b2 dual variable domain immunoglobulin in patients with osteoarthritis of the knee: a randomized phase 1 study","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2017.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.","name":"copyright","label":"Copyright"}]}}